Artificial Intelligence
(AI)
in Drug Discovery Market
Artificial Intelligence (AI) in Drug Discovery Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Artificial Intelligence (AI) in Drug Discovery Market Size and Growth
The global Artificial Intelligence (AI) in Drug Discovery market is experiencing significant growth due to the increasing adoption of AI technology in pharmaceutical research and development. The market size is expected to reach USD 6.3 billion by 2026, driven by the demand for innovative and efficient solutions for drug discovery processes.
Sample Report
Request
Companies Covered (Covid 19 Impact Covered)
◍ IBM
◍ Microsoft
◍ NVIDIA Corporation
◍ Atomwise, Inc.
◍ Deep Genomics
◍ Cloud Pharmaceuticals
◍ Insilico Medicine
◍ BenevolentAI
◍ Exscientia
◍ Cyclica
◍ BIOAGE
◍ Numerate
◍ NuMedii
◍ Envisagenics
◍ twoXAR
◍ OWKIN, Inc.
◍ XtalPi
The competitive landscape of AI in drug discovery market includes companies like IBM, Microsoft, Google, NVIDIA Corporation, Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Insilico Medicine, BenevolentAI, Exscientia, Cyclica, BIOAGE, Numerate, NuMedii, Envisagenics, twoXAR, OWKIN, Inc., XtalPi, Verge Genomics, and BERG LLC. These companies leverage AI technologies such as machine learning, deep learning, and data analytics to accelerate drug discovery process, identify potential drug candidates, optimize drug development, and personalize medicine. Sales revenue figures (in millions): NVIDIA Corporation - $10.92B, IBM$77.14B, Microsoft - $138B.
Request Sample Report
Market Segmentation
By Application
◍ Pharmaceutical & Biotechnology Companies
◍ Contract Research Organizations
◍ Research Centers and Academic & Government Institutes
By Product
◍ Software
◍ Services
Request Sample Report
$ X Billion USD
Market Growth
Request Sample Report
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients